Amelioration of bone loss in collagen-induced arthritis by neutralizing anti-RANKL monoclonal antibody.

Kamijo, Seiji; Nakajima, Atsuo; Ikeda, Kaori; Aoki, Kazuhiro; Ohya, Keiichi; Akiba, Hisaya; Yagita, Hideo; Okumura, Ko

Kamijo, Seiji; Nakajima, Atsuo; Ikeda, Kaori; Aoki, Kazuhiro; Ohya, Keiichi; Akiba, Hisaya; Yagita, Hideo; Okumura, Ko.

Affiliation

Kamijo S; Department of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan. s-kamijo@med.juntendo.ac.jp

Biochem Biophys Res Commun ; 347(1): 124-32, 2006 Aug 18.

Article in En | MEDLINE | ID: mdl-16815304

Subject(s)

Antibodies, Monoclonal/administration & dosage; Arthritis/immunology; Arthritis/prevention & control; Bone Resorption/immunology; Bone Resorption/prevention & control; Carrier Proteins/immunology; Membrane Glycoproteins/immunology; Animals; Antibodies, Monoclonal/immunology; Arthritis/chemically induced; Arthritis/pathology; Bone Resorption/chemically induced; Bone Resorption/pathology; Collagen; Male; Mice; Mice, Inbred DBA; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arthritis / Bone Resorption / Membrane Glycoproteins / Carrier Proteins / Antibodies, Monoclonal Limits: Animals Language: En Journal: Biochem Biophys Res Commun Year: 2006 Document type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links